ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,973Medicare Part D Prescriptions Filled, Including Refills

Rank: 310 out of 676

$262K Total Retail Price of All Prescriptions

Rank: 377 out of 676

161 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
72% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Mississippi
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 161 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

42% of this provider’s 161 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

1% of this provider’s 4,377 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $50 among peers.

Prescriptions per Patient

43 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Mississippi
PRAVASTATIN SODIUM 443 308 1 11
HYDROCODONE-ACETAMINOPHEN 443 233 S3 1 1
OMEPRAZOLE 297 152 3 2
AMLODIPINE BESYLATE 265 203 4 3
LISINOPRIL 238 176 5 5
POTASSIUM CHLORIDE 214 137 6 9
METFORMIN HCL 145 65 7 8
METOPROLOL SUCCINATE 139 99 8 14
HYDROCHLOROTHIAZIDE 139 86 8 12
FUROSEMIDE 134 94 10 4
METOPROLOL TARTRATE 132 102 11 22
CITALOPRAM HBR 116 80 12 17
GABAPENTIN 109 47 13 10
ZOLPIDEM TARTRATE 108 57 14 21
ALLOPURINOL 107 90 15 31
ENALAPRIL MALEATE 106 72 16 65
SERTRALINE HCL 103 67 17 26
LEVOTHYROXINE SODIUM 88 67 18 7
TRAZODONE HCL 86 39 19 36
AMITRIPTYLINE HCL 82 16 R 20 46
ATENOLOL 80 57 21 25
CARVEDILOL 77 40 22 15
WARFARIN SODIUM 76 58 23 18
POLYETHYLENE GLYCOL 3350 75 62 24 56
DIOVAN HCT 72 33 25 41
CHLORTHALIDONE 66 39 26 164
DOXYCYCLINE HYCLATE 62 27 27 82
DONEPEZIL HCL 57 57 28 24
DIOVAN 56 44 29 37
CLOPIDOGREL 54 39 30 28
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 47 31 16
SYNTHROID 52 44 32 48
LEVOTHROID 52 35 32 268
ENDOCET 51 25 S2 34 104
DOXAZOSIN MESYLATE 50 41 35 116
CYCLOBENZAPRINE HCL 50 0 R 35 50
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 25, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.